Adjuvant or neoadjuvant chemotherapy for NSCLC. - Wikidata - awgldk - TriplyDB

Adjuvant or neoadjuvant chemotherapy for NSCLC.

Adjuvant or neoadjuvant chemotherapy for NSCLC.

http://www.wikidata.org/entity/Q33658228

about

Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection.High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients.Selection for adjuvant chemotherapy in completely resected stage I non-small cell lung cancer: external validation of a Chinese prognostic risk model CACNA1B (Cav2.2) Overexpression and Its Association with Clinicopathologic Characteristics and Unfavorable Prognosis in Non-Small Cell Lung Cancer.High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer.Apoptosis of Lewis Lung Carcinoma Cells Induced by Microwave via p53 and Proapoptotic Proteins In vivo.Activating transcription factor 2 expression mediates cell proliferation and is associated with poor prognosis in human non-small cell lung carcinoma.Development and validation of two prognostic nomograms for predicting survival in patients with non-small cell and small cell lung cancer.Is single-station N2 disease on PET-CT an indication for primary surgery in lung cancer patients?Outcomes of neoadjuvant and adjuvant chemotherapy in stage 2 and 3 non-small cell lung cancer: an analysis of the National Cancer Database.

P2860

Q34316969-FA4439DF-3B58-4723-B881-213F860D597A Q34956692-EBF084AF-4FC0-476F-8D79-2500179800B9 Q36540398-5C79E6E0-43BC-45F3-B23D-A7D6E5026315 Q37588691-A5E0A56A-9D25-4EA4-9014-65CDB53085EA Q37706501-C06865CB-9EE8-4162-B990-CA4C1AFEEF38 Q38723069-EC365C45-7040-4168-9887-AB3BAF246F84 Q40002473-155A52B3-9500-4E3A-9610-B75142CEC5F7 Q42362788-CA0FD434-EE66-4946-B98D-BF8BE827A190 Q47187353-5924A098-31D9-4A3A-A2F0-0D8F7DDB4E6C Q54961303-881989AF-6CF5-4AF3-9BCC-632CC3447C45

P2860

Adjuvant or neoadjuvant chemotherapy for NSCLC.

http://www.wikidata.org/entity/Q33658228

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Adjuvant or neoadjuvant chemotherapy for NSCLC.

@ast

Adjuvant or neoadjuvant chemotherapy for NSCLC.

@en

type

label

Adjuvant or neoadjuvant chemotherapy for NSCLC.

@ast

Adjuvant or neoadjuvant chemotherapy for NSCLC.

@en

prefLabel

Adjuvant or neoadjuvant chemotherapy for NSCLC.

@ast

Adjuvant or neoadjuvant chemotherapy for NSCLC.

@en

P1433

Q33658228-E463DBC6-50C7-469A-89BC-45497AB829E0

P1476

Q33658228-588434E2-FBC1-4D37-BA3B-9D4DC6BAFCD3

P2093

Q33658228-8E974ED4-F095-4052-B15F-9FD5B0049AFD

Q33658228-F3C7BC91-5A8E-4128-8625-BFF8631093B1

P2860

Q33658228-2E6C92DE-D2E6-422D-A52F-AE61F3493957

Q33658228-64B5AF31-6FFF-4ABC-8C54-874E30FBBB0F

Q33658228-741B319D-CA17-4FC3-9DBF-F9599C97FB86

Q33658228-85B2BB10-AB65-46B4-99CC-EADD5EB12C18

Q33658228-931ED284-0AFE-4BEE-B7ED-386F4218D8FD

Q33658228-A6117335-7ACF-4C20-BE0E-90527B8B11FB

Q33658228-B0A4F1C0-50A6-48EC-852F-118EE0F0829F

Q33658228-B4D72933-951D-4B7A-BF9A-469C7D8DC7C8

Q33658228-BA36F474-6E7E-4026-84AA-0812B27D6B45

Q33658228-E7B898E0-77ED-41A8-8E18-50709F9C882A

P304

Q33658228-C6F9315D-80D3-4F6E-A945-1B4765D06350

P31

Q33658228-E8A4B999-B50C-4E77-AA75-500A5DB4BE23

P356

Q33658228-8207AD74-1971-4BD9-BDC8-3F72F2FE2333

P478

Q33658228-D14A076B-FC74-42F1-BF7B-D82854ADA6BE

P50

Q33658228-ABEE3DBC-79A1-440D-BEBC-28B173010064

Q33658228-C71EDE64-6BD9-45A7-AD26-074E98300576

P577

Q33658228-4D342D0E-209F-4E53-A186-62DA24B0B38F

P698

Q33658228-938D070F-555D-4B87-B073-CC0F053EFD30

P921

Q33658228-713BE075-2AEE-4B36-8B51-D9CC32C4A04B

P932

Q33658228-36FDF3B1-ED10-4735-B81C-30B079FD13AD

P356

J.ISSN.2072-1439.2014.04.26

P1433

Journal of thoracic disease

P1476

Adjuvant or neoadjuvant chemotherapy for NSCLC

@en

P2093

Eric Lim

http://www.w3.org/2001/XMLSchema#string

Philip McElnay

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.

Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers.

Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.

Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Preoperative versus postoperative chemotherapy in patients with resectable non-small cell lung cancer: systematic review and indirect comparison meta-analysis of randomized trials.

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

P304

S224-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2072-1439.2014.04.26

http://www.w3.org/2001/XMLSchema#string

P478

6 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24868440

http://www.w3.org/2001/XMLSchema#string

P921

P932

4032958

http://www.w3.org/2001/XMLSchema#string